lgbtDB

(Q32403)

Statements

title
Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen. (English)
1 reference
stated in
PubMed
other abstract
This study examines prostate-specific antigen values among transgender women in the Veterans Health Administration receiving estrogen. (English)
series ordinal
1
type
plain-language summary
1 reference
stated in
PubMed
date published
23 July 2024
1 reference
stated in
PubMed
date issued
23 July 2024
1 reference
stated in
PubMed
author
volume
332
1 reference
stated in
PubMed
issue
4
1 reference
stated in
PubMed
page(s)
335-337
1 reference
stated in
PubMed
page start
335
1 reference
stated in
PubMed
page end
337
1 reference
stated in
PubMed
date of article
unknown value
1 reference
stated in
PubMed
conflict-of-interest statement
<b>Conflict of Interest Disclosures:</b> Dr Cooperberg reported receiving personal fees from Janssen, AstraZeneca, Astellas, Pfizer, Bayer, Verana Health, Veracyte, Lynx Dx, ExoDx, and Merck outside the submitted work. (English)
series ordinal
1
1 reference
stated in
PubMed
No other disclosures were reported. (English)
series ordinal
2
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q32403&oldid=190671"